Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs

Conclusion Long-term nucleos(t)ide analog therapy does not guarantee against the HCC development and mortality in chronic hepatitis B-related cirrhotic patients. Careful HCC surveillance is necessary in patients with old age, statin use, low platelet count, and variceal bleeding history.
Source: Journal of the Formosan Medical Association - Category: Journals (General) Source Type: research